Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease Eda Kaya; Eduardo Vilar-Gomez; Raj Vuppalanchi; Yusuf Yilmaz;

Assessment of metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population Jorge Emilio Lira-Vera; Ángel Daniel Santana-Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Yadira Lilian Béjar-Ramírez; José Luis Pérez-Hernández;

Is FIB-4 the right tool for screening for liver fibrosis? Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;